Pharmacology of the receptors for the phorbol ester tumor promoters
- 2 October 2000
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 60 (10) , 1417-1424
- https://doi.org/10.1016/s0006-2952(00)00470-6
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Treatment of patients with metastatic melanoma with bryostatin-1 - phase II studyMelanoma Research, 1999
- Transient, Phorbol Ester-induced DOC2-Munc13 Interactions in VivoJournal of Biological Chemistry, 1999
- Probing the Binding of Indolactam-V to Protein Kinase C through Site-Directed Mutagenesis and Computational Docking SimulationsJournal of Medicinal Chemistry, 1999
- Inhibition of Membrane Lipid-independent Protein Kinase Cα Activity by Phorbol Esters, Diacylglycerols, and Bryostatin-1Journal of Biological Chemistry, 1998
- Lipid Structure and Not Membrane Structure Is the Major Determinant in the Regulation of Protein Kinase C by PhosphatidylserineBiochemistry, 1998
- RasGRP, a Ras Guanyl Nucleotide- Releasing Protein with Calcium- and Diacylglycerol-Binding MotifsScience, 1998
- Taxonomy and function of C1 protein kinase C homology domainsProtein Science, 1997
- Protein kinase C: a worthwhile target for anticancer drugs?Anti-Cancer Drugs, 1997
- Crystal structure of the Cys2 activator-binding domain of protein kinase Cδ in complex with phorbol esterPublished by Elsevier ,1995
- Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skinCarcinogenesis: Integrative Cancer Research, 1987